SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053036
Filing Date
2020-11-10
Accepted
2020-11-10 17:04:19
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-10q_20200930.htm 10-Q 2735161
2 EX-31.1 alvr-ex311_6.htm EX-31.1 19020
3 EX-31.2 alvr-ex312_8.htm EX-31.2 19061
4 EX-32.1 alvr-ex321_9.htm EX-32.1 9667
5 EX-32.2 alvr-ex322_7.htm EX-32.2 9709
  Complete submission text file 0001564590-20-053036.txt   7612082

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alvr-20200930.xml EX-101.INS 1381243
7 XBRL TAXONOMY EXTENSION SCHEMA alvr-20200930.xsd EX-101.SCH 56143
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alvr-20200930_cal.xml EX-101.CAL 40021
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alvr-20200930_def.xml EX-101.DEF 175206
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20200930_lab.xml EX-101.LAB 398885
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20200930_pre.xml EX-101.PRE 318647
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 201302032
SIC: 2836 Biological Products, (No Diagnostic Substances)